The in vitro study on genotoxic activity of adriamycin and bleomycin in cells of mice with different catalase and superoxide dismutase activity

Acta Poloniae Pharmaceutica - Drug Research

Volumn 54, Issue 6, 1997, Pages 437-441

  Chłopkiewicz, Bozena ^a   Gruber, Beata ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Active oxygen species; Adriamycin; Bleomycin; Catalase; Micronucleus test; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; BLEOMYCIN; CATALASE; DOXORUBICIN; EPIRUBICIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; GENOTOXICITY; MICRONUCLEUS TEST; MOUSE; NONHUMAN; TOXICITY TESTING;

ANIMALS; BLEOMYCIN; CATALASE; DOXORUBICIN; FIBROBLASTS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICRONUCLEUS TESTS; SUPEROXIDE DISMUTASE;

EID: 0342943115     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Young R.C., Ozols R.F., Myers C.E.N.: Engl. J. Med. 305, 131 (1981).
2. Crooke S.T. in: S.K. Carter, S.T. Croke, H. Umezawa (Eds.), Bleomycin: Current Status and New Developments, Academic Press, New York, pp. 1-4 (1978).
3. Pigram W.J., Fuller W., Hamilton L.D.: Nature 253, 17 (1972).
4. Vig B.K.: Cancer Res. 31, 32 (1971).
5. Vig B.K.: Mutation Res. 39, 189 (1977).
6. Vig B.K.: Cancer Chemother. Pharmacol. 3, 143 (1979).
7. Al-Shabanah O.A.: Mutation Res. 301, 107 (1933).
8. Bachur N.R., Gordon S.L., Gee M.V.: Cancer Res. 38, 1745 (1978).
9. Santo S., Iwaizumi M., Handa K., Tamura Y.: Gann 68, 603 (1977).
10. Doroshow J.H.: Cancer Res. 43, 460 (1983).
11. Suzuki H., Nagai K., Yamaki H., Tanaka N., Umezawa H.J.: Antibiot. (Tokyo) Ser. A 21, 379 (1968).
12. Povirk L.F., Austin M.J.F.: Mutation Res. 257, 127 (1991).
13. Fujiwara Y., Kondo T.: Biochem. Pharmacol. 22, 323 (1973).
14. Haidle C.W.: Mol. Pharmacol. 7, 645 (1971).
15. Dresp J., Schmid E., Bauchinger M.: Mutation Res. 56, 341 (1978).
16. Hoffman G.R., Colyer S.P., Littefield L.G.: Environ. Mol. Mutagen. 21, 130 (1993).
17. Burger R.M., Peisach J., Horwitz S.B.: J. Biol. Chem. 22, 11636 (1981).
18. Burger R.M., Peisach J., Blumberg W.E., Horwitz S.B.: J. Biol. Chem. 254, 10906 (1979).
19. Povirk L.F.: Biochemistry 18, 3989 (1979).
20. Sausville E.A., Peisach J., Horwitz S.B.: Biochemistry 17, 2740 (1978).
21. Matsuoka A., Yamazaki N., Suzuki T., Hayashi M., Sofuni T.: Mutation Res. 272, 223 (1993).
22. Heddle J.A., Hite M., Kirkhart B., Mavournin K., MacGregor J.T., Newell G.W., Salamone M.F.: Mutation Res. 123, 61 (1983).
23. Hoffman A., Rechcigl M.: Enzyme 12, 219 (1971).
24. Ito A., Watanabe H., Naito M., Naito Y., Kawashima K.: Gann 75, 17 (1984).
25. Rechcigl M. Jr., Heston W.E.: J. Nat. Cancer Inst. 30, 855 (1963).
26. Ejchart A., Chłopkiewicz B.: Acta Polon. Pharm. - Drug Research 53, 357 (1996).
27. Larramendy M.L., Bianchi M.S., Padron J.: Mutation Res. 214, 129 (1989).
28. Emerit I. in: A T. Natarajan et al. (Eds.), Progress in Mutation Research, Vol. 4, Elsevier, Amsterdam, pp. 61-74 (1982).
29. Sofuni T., Ishidate M.: Mutation Res. 140, 27 (1984).
30. Tewey K.M., Rowe T.C., Yang L., Halligan B.D., Liu L.F.: Science 226, 466 (1984).
31. Potmesil M., Kirschenbaum S., Israel M., Levin M., Khetarpol V.K., Silber R.: Cancer Res. 43, 3528 (1983).
32. Capranico G., Babudri N., Casciarri G., Dolzani L., Gambetta R.A., Longoni E., Pani B., Soranzo C., Zunino F.: Chem. Biol. Interact. 47, 189 (1986).